by Rhoda Wilson, Expose News:

A recent article published in The British Medical Journal (“The BMJ”) details the debate that has broken out over whether Pfizer should have told pregnant women participating in its trial of maternal respiratory syncytial virus (“RSV”) vaccination that a trial of GSK’s similar vaccine was halted over a safety signal around pre-term birth.

Pfizer’s maternal RSV vaccine is called Abrysvo.